BigOmics–SEVERAL: investment, 202510 financing round 1st tranche $1.6m from Diffusion Capital Partners + business angels + TiVentures et al

	Period	2025-10-08
	Money taker	BigOmics Analytics S.A.
	Money source	SEVERAL
	Product	Omics Playground platform
	Product 2	venture capital

BigOmics Analytics S.A.. (10/8/23). "Press Release: BigOmics Analytics Successfully Completes the First Tranche of its Next Round to Fast-track Omics Data Analysis and Unlock Precision Medicine". Lugano.

BigOmics Analytics, a Swiss bioinfor^matics company empowering scientists to analyze omics data with its intelligent tools, today announced the successful first tranche of next funding round, raising $1.6M. The round was backed by new investors Diffusion Capital Partners and business angels from the SICTIC network, alongside continued support from existing investors, including TiVentures.

The new capital will fuel BigOmics’ mission to make omics and multi-omics data analysis faster, simpler, and more accessible for life scientists worldwide. BigOmics’ platform – Omics Playground – provides an intuitive cloud-based solution enabling researchers to explore, visualize, and interpret complex transcriptomics, proteomics, metabolomics and lipidomics datasets. It is a collaborative infrastructure that enables data scientists and biologists to interactively share insights, unify data in a single platform to eliminate silos, and ensure results that are both reproducible and robust.

“Closing this round is a milestone for BigOmics and a strong validation of our vision. This investment allows us to accelerate product development, expand into new markets, and bring omics data analysis to every lab bench”, said Murat Akhmedov, co-founder and CEO of BigOmics Analytics. “We believe the future of life sciences lies in empowering researchers to analyze and interpret insights from their data directly and in real time”, said Ivo Kwee, CTO and co-founder of the company.

BigOmics has built a global community of more than 6,000 researchers, and over 60 biotech & pharma companies and institutes use its platforms to streamline data discovery and accelerate insights in cancer research, neurodegenerative diseases, immunology and beyond.

“With the explosion of omics data, tools that lower the barrier to analysis are crucial for the next wave of biomedical breakthroughs. We are excited to back their vision”, said Alper Karagöz, Partner at Diffusion Capital Partners. “BigOmics stands out as a category-defining company with the technology and team to become the go-to platform for omics data analysis”, said Lorenzo Leoni, Managing Partner at TiVentures.

The funding will be used to expand product development and enhance AI-powered capabilities for deeper biological insights, increase customer success and serve a growing global user base, and scale infrastructure for enterprise and clinical applications.

About BigOmics Analytics

BigOmics Analytics is a Swiss bioinformatics company dedicated to fast-track omics data analysis to enable precision medicine. With its cloud-native platform Omics Playground, BigOmics empowers biologists and data scientists to explore, visualize, and interpret complex omics datasets and share their insights interactively, fostering efficient collaboration. BigOmics is headquartered in Lugano, Switzerland.

Omics Playground
Omics Playground interface

About Diffusion Capital Partners (DCP)

Diffusion Capital Partners (DCP) is a venture capital firm that invests in deep tech startups and supports disruptive technologies across Türkiye and Europe

About TiVentures

TiVentures is a Switzerland-based venture firm investing in pioneering biotech, medtech, and high-tech companies with global growth potential.